Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes

被引：10
作者：
Schmid, C. [2 ]
Krayenbuhl, P. [3 ]
Wiesli, P. [1 ]
机构：
[1] Kantonsspital, Med Klin, CH-8500 Frauenfeld, Switzerland
[2] Univ Zurich Hosp, Dept Internal Med, Div Endocrinol & Diabet, Zurich, Switzerland
[3] Univ Zurich Hosp, Dept Internal Med, Med Policlin, Zurich, Switzerland
来源：
DIABETOLOGIA | 2009年 / 52卷 / 12期
关键词：
Hyperinsulinaemia; Insulin dose requirement; Long-acting insulin analogues; Obesity; Type; 2; diabetes; TO-TARGET TRIAL; NPH INSULIN; THERAPY; GLARGINE; DETEMIR;
D O I：
10.1007/s00125-009-1534-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2668 / 2669
页数：2
相关论文
共 50 条
[41]   Glycaemic control in patients with type 2 diabetes switching from premixed insulin to long-acting basal insulin analogue plus oral antidiabetic drugs: an observational study [J].
Gomez-Peralta, F. ;
Carraminana-Barrera, F. ;
Felix-Redondo, F. J. ;
Fraile-Gomez, J. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (10) :959-968
[42]   Pharmacodynamics of the long-acting insulin analogues detemir and glargine following single-doses and under steady-state conditions in patients with type 1 diabetes [J].
Koehler, G. ;
Treiber, G. ;
Wutte, A. ;
Korsatko, S. ;
Mader, J. K. ;
Semlitsch, B. ;
Pieber, T. R. .
DIABETES OBESITY & METABOLISM, 2014, 16 (01) :57-62
[43]   The effect of the optimal use of rapid-acting insulin analogues on insulin secretion in Type 2 diabetes [J].
Gallagher, A. ;
Butler, T. J. ;
Home, P. D. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2007, 76 (03) :327-334
[44]   Long-acting insulin analogues. Drug selection by means of the System of Objectified Judgement Analysis (SOJA) [J].
Janknegt, Robert ;
Dankers, Marloes .
GABI JOURNAL-GENERICS AND BIOSIMILARS INITIATIVE JOURNAL, 2022, 11 (01) :25-33
[45]   A nationwide cohort study for comparative vascular safety of long-acting insulin analogue versus intermediate-acting human insulin in type 2 diabetes [J].
Yang, Chun-Ting ;
Li, Kuan-Ying ;
Yang, Chen-Yi ;
Ou, Huang-Tz ;
Kuo, Shihchen .
SCIENTIFIC REPORTS, 2021, 11 (01)
[46]   NEWER LONG-ACTING BASAL INSULIN PREPARATIONS [J].
Blonde, Lawrence .
ENDOCRINE PRACTICE, 2017, 23 :13-17
[47]   Oral Therapies for Type 2 Diabetes in Combination With Long-acting Insulin and the Risks of Myocardial Infarction and Stroke [J].
Floyd, James S. ;
Wiggins, Kern L. ;
Dublin, Sascha ;
Longstreth, William T. ;
Smith, Nicholas L. ;
McKnight, Barbara ;
Heckbert, Susan R. ;
Weiss, Noel S. ;
Psaty, Bruce M. .
CIRCULATION, 2015, 132
[48]   Management of Diabetic Cats with Long-acting Insulin [J].
Roomp, Kirsten ;
Rand, Jacquie S. .
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE, 2013, 43 (02) :251-+
[49]   Insulin Analogues Insulin Glargine and Insulin Glulisine in Type 1 Diabetes [J].
Schreiber, S. A. ;
Fiesselmann, A. ;
Bornstein, S. R. ;
Landgraf, W. .
DIABETES STOFFWECHSEL UND HERZ, 2011, 20 (02) :69-77
[50]   Insulin analogues dosing and costs - comparing real-life daily doses of insulin detemir and insulin glargine in type 2 diabetes patients [J].
Jakobsen, Marie ;
Dalsgaard, Mette ;
Hormann, Morten ;
Moller, Daniel Vega .
BMC ENDOCRINE DISORDERS, 2012, 12
12345